Mutual of America Capital Management LLC Sells 1,087 Shares of Moderna, Inc. (NASDAQ:MRNA)
Mutual of America Capital Management LLC trimmed its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 2.6% during the ...
Business Insider29d
Could Moderna’s (MRNA) 65% Stock Plunge Entice a Takeover?
This is a significant shift from the previous quarter when Moderna’s Q3 2024 results showcased resilience. Goldman Sachs Weighs in on Moderna Stock While Moderna’s Q4 earnings may represent a ...
Business Insider28d
Moderna (MRNA) Is About to Report Tomorrow. Here Is What to Expect
Also, Goldman Sachs recently added to the bearish outlook on Moderna, downgrading the stock to Hold and cutting its price target from $99 to $51, citing continued revenue guidance reductions and ...
Goldman Sachs' annual culling of underperformers is coming earlier than usual this year
Goldman Sachs trims its staff, cutting what it deems to be the underperformers. This year, VPs stand to be big targets, BI ...
Yahoo Finance27d
Moderna Reports Another Quarterly Loss
Moderna Inc. recorded another quarterly loss as vaccine sales wane and the company had an unexpected charge for canceled manufacturing contract. Goldman Sachs US Biotechnology Analyst Salveen ...
Hedge funds unwinding risk as in early days of COVID, Goldman Sachs says
Hedge funds unwound positions in single stocks on Friday at the largest amount in over two years, with some activity ...
The Motley Fool1mon
Is Goldman Sachs Stock a Buy Now?
Goldman Sachs has rebounded significantly, with its stock up 116% since November 2023. The company's earnings exceeded expectations, driven by increased M&A and IPO activities. Some analysts ...